Presentation

RE-VERSE AD: Idarucizumab for Dabigatran Reversal

Presenter: Charles V. Pollack Jr

June 24, 2015

REGISTER for free or LOG IN to view this content

RE-VERSE AD: Idarucizumab for Dabigatran Reversal

Coronary

CAD Pharma

Factoid

Up Next

Presentation

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Presenter: Kenneth Rosenfield

June 25, 2015

More slides +

Presentation ISET 2015

Update on Peripheral Artery Stent Surveillance: Have We Learned Anything from Clinical Trials?

Presenter: Michael R. Jaff

January 31, 2015

Presentation

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Pts With Severe Symptomatic Aortic Stenosis Undergoing TAVR

Presenter: CJ. O'Sullivan

August 04, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.